Study to Assess the Safety and Tolerability of PBF-1650 in Healthy Volunteers.
Clinical trial NCT03798236 · COMPLETED
Trial details
- NCT number
- NCT03798236
- Sponsor
- Palobiofarma SL
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-10
- Primary completion
- 2019-03-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.